CliCr® and CliCr® derivatives are available via Iris Biotech GmbH

January 26, 2023

CliCr® and CliCr® derivatives are available via Iris Biotech GmbH

As per 25 January 2023, Iris Biotech sells CliCr® and CliCr® reagents for non-GXP research purposes. 
For GXP applications, parties are to connect with Cristal Therapeutics.

Read more information on https://www.iris-biotech.de/de/blog/potm-clicrr-an-innovative-click-reagent/

 

 

Home > News > CliCr® and CliCr® derivatives are available via...

© 2024 Aglaia Oncology Funds | Privacy | Sitemap
Aglaia Oncology Funds